<DOC>
	<DOCNO>NCT02191579</DOCNO>
	<brief_summary>This study evaluate efficacy , safety tolerability prophylactic ( preventative ) treatment BOTOX® ( onabotulinumtoxinA ) compare topiramate adult chronic migraine .</brief_summary>
	<brief_title>Efficacy Safety Study BOTOX® Compared Topiramate Prevention Chronic Migraine Adults</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>History chronic migraine More 15 headache day 28 day period ( headache last 4 hour and/or require treatment prescription medication ) . Taking opioidcontaining product acute headache treatment 8 day 28day period Previous treatment botulinum toxin serotype reason Previous treatment topiramate On ketogenic diet ( high fat , low carbohydrate ) History acute myopia increase intraocular pressure Diagnosis myasthenia gravis , EatonLambert syndrome , amyotrophic lateral sclerosis significant disease might interfere neuromuscular function Acupuncture , transcutaneous electrical stimulation ( TENS ) , cranial traction , dental splint headache , injection anesthetics/steroids 4 week prior screen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>